Telesis Bio Inc (NASDAQ:TBIO) does about 78.03K shares in volume on a normal day but saw 2934045 shares change hands in the recent trading day. The company now has a market cap of 9.24M USD. Its current market price is $5.50, marking an increase of 30.33% compared to the previous close of $4.22. The 52 week high reached by this stock is $27.54 whilst the lowest price level in 52 weeks is $3.03.
Telesis Bio Inc (TBIO) has a 20-day trading average at $4.05 and the current price is -80.03% off the 52-week high compared with 81.82% distance from its 52-week low. The 50-day simple moving average of the closing price is $3.90 and its 200-day simple moving average is $6.94. If we look at the stock’s price movements over the week, volatility stands at 37.55%, which decreases to 17.16% over 1 month. It is also key to look at other market indicators of price movement for the stock, where we see that the relative strength index (RSI) is at 68.66 to suggest the stock is neutral.
The consensus objective for the share price is $72.00, suggesting that the stock has a potential upside of 92.36% over the period.
0 analysts have rated it as a buy and 0 have advised that investors hold their positions. The consensus recommendation rating is nan and Wall Street’s advice is for investors to Strong Buy the stock.
Telesis Bio Inc (TBIO) stock is up 34.15% over the week and 45.50% over the past month. Its price is -23.42% year-to-date and -79.21% over the past year.
The stock last released its quarterly earnings report for quarter ended 3/31/2024, with the company’s earnings per share (EPS) of -5.04 above consensus estimates by 0.72. The company’s next earnings report forecasts estimating quarterly EPS at -4.03 and -15.17 for whole year. Expected sales for next quarter are $7.9M, which analysts say will come at $26.8M for the current fiscal year and next year at $37M. In addition, estimates put the company’s current quarterly revenue at an average of $6.5M.
To reach the target analysts have set, the stock logically needs to grow 92.36 percent from here.
Outstanding shares total 1.67M with insiders holding 40.18% of the shares and institutional holders owning 36.74% of the company’s common stock. The company has a return on investment of -83.01% and return on equity of -155.29%. The beta has a value of 1.70. Price to sales ratio is 0.38.
